Research

Mira's Clinical Validation — Provider Reference

Mira's clinical validation, organized by evidence strength — from gold-standard ultrasound studies to independent academic replication.

Validating ovulation prediction and confirmation with the Mira monitor: blinded ultrasound and serum hormone comparison

A blinded study in Reproductive BioMedicine Online compared Mira with transvaginal ultrasound and blood tests in 52 participants with regular cycles. Mira’s LH peak fell within ±1 day of ultrasound-confirmed ovulation in 96% of ovulations, and urine hormone levels correlated strongly with serum.

Preliminary laboratory analytical comparison of quantitative at-home urinary hormone monitoring systems using artificial urine

A laboratory comparison of five quantitative at-home hormone monitor setups, published in Frontiers in Endocrinology. Mira was the only monitor tested to detect E₁3G (estrogen) at or below 50 ng/mL, with consistent precision for LH, FSH and E₁3G.

Comparison of Day-Specific Serum LH, Estradiol, and Progesterone with MiraTM Monitor Urinary LH, Estrone-3-glucuronide, and Pregnanediol-3-glucuronide Levels in Ovulatory Cycles

Blood glucose variance measured by continuous glucose monitors across the menstrual cycle

Intelligent algorithm combined with a device that detects luteinizing hormone levels can improve the prediction accuracy of ovulation day

A New Protocol for Controlled Ovarian Stimulation Monitoring by Self-Determination of Estrone-3-Glucuronide and Single Ultrasound (COSSESU)

At-home urine estrone-3-glucuronide quantification predicts oocyte retrieval outcomes comparably to serum estradiol.